Modulation of in vivo immune response by selective depletion of neutrophils using a monoclonal antibody, RP-3. I. Inhibition by RP-3 treatment of the priming and effector phases of delayed type hypersensitivity to sheep red blood cells in ratsChie Kudo, Fujiro Sendo, Tadashi Watanabe et al.|The Journal of Immunology|1993Cited by 55
Novel Treatment of chronic GVHD in Mice Using the ER Stress Reducer PBAEisuke Shimizu, Tsubota Kazuo, Ogawa Yoko et al.|日本角膜学会総会・日本角膜移植学会プログラム・抄録集|2017Cited by 0